Combined chemotherapy in the management of metastatic bladder cancer.
D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008937:Mitomycins / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D008937:Mitomycins; D004317:Doxorubicin; D013713:Teniposide; D011034:Podophyllotoxin; D005472:Fluorouracil